A Multi-Omics Platform for Comprehensive pHLA Target Discovery & Validation
- Leveraging state-of-the-art immunopeptidomics to map and quantify the pHLA target landscape
- Combining immunopeptidomics with complementary OMICS approaches to identify and validate novel peptide targets, driving the development of TCR-based immunotherapies and beyond
- Pushing past barriers of detection and quantification of even low-abundance pHLA targets through cutting-edge technology, unlocking new therapeutic opportunities